Cancer

2012 – Isolation and Characterization of Tumor Initiating Cells in Canine Osteosarcoma Cell Lines (AKC CHF) $1,000
2008 – $2,500 AKC/CHF Grant #1113 – Dr. Timothy D. O’Brien, DVM, PhD – Univ of Minnesota – Canine Non-Hodgkin Lymphoma: Characterization and Prognostic Value of Cancer Stem Cells Amount: $150,071.40 |  $2,500 AKC/CHF Grant #1139 – Dr. Nicola Mason, BVetMed, DACVIM, PhD – Univ of Penn – Immune Targeting of Canine Hemangiosarcoma Using a Canine Derived Single Chain Antibody Approach Amount: $123,125.40
2006 – $1,700 With AKC CHF Grant 652: William Kisseberth, DVM, PhD, Ohio State University • MicroRNAs and Canine Lymphoma | $5,000 With AKC CHF
#615B, North Carolina State University • Heritable and Sporadic Genetic Lesions in Canine Lymphoma Two years
2005 – $5,000 With AKC CHF, Auburn University • Investigation of Predicators of Outcome for Canine Mast Cell Tumors | $2,500 With AKC CHF, Cornell University • Anti-HLA-DR Antibody Therapy in Canine B-Cell Lymphoma: Preliminary Clinical Evaluation
2004 – $2,500 With AKC CHF, University of Wisconsin • An Investigation into Combined Molecular Approaches to Treat Hemangiosarcoma | $5,000 With AKCCHF, Ohio State University • Oligonucleotide Microarray Gene Expression Profiling of Canine Lymphoma
2003 – $10,000 With AKC CHF: Matthew Breen, PhD, at North Carolina State University, “Cellular Genomics – A Cytogenetic Investigation of Canine Soft Tissue Sarcomas”
2002 – $9,800 With AKC CHF • Identification of Characterization of Genetic Mutation in Canine Cell Tumors